AAAAAA

   
Results: 1-6 |
Results: 6
High-affinity monoclonal antibodies to PED/PEA-15 generated using 5 mu g of DNA
Authors: Kilpatrick, KE Danger, DP Hull-Ryde, EA Dallas, W
Citation: Ke. Kilpatrick et al., High-affinity monoclonal antibodies to PED/PEA-15 generated using 5 mu g of DNA, HYBRIDOMA, 19(4), 2000, pp. 297-302
Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro
Authors: Su, JL Winegar, DA Wisely, GB Sigel, CS Hull-Ryde, EA
Citation: Jl. Su et al., Use of a PPAR gamma-specific monoclonal antibody to demonstrate thiazolidinediones induce PPAR gamma receptor expression in vitro, HYBRIDOMA, 18(3), 1999, pp. 273-280
A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation
Authors: Oberfield, JL Collins, JL Holmes, CP Goreham, DM Cooper, JP Cobb, JE Lenhard, JM Hull-Ryde, EA Mohr, CP Blanchard, SG Parks, DJ Moore, LB Lehmann, JM Plunket, K Miller, AB Milburn, MV Kliewer, SA Willson, TM
Citation: Jl. Oberfield et al., A peroxisome proliferator-activated receptor gamma ligand inhibits adipocyte differentiation, P NAS US, 96(11), 1999, pp. 6102-6106
N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents
Authors: Henke, BR Blanchard, SG Brackeen, MF Brown, KK Cobb, JE Collins, JL Harrington, WW Hashim, MA Hull-Ryde, EA Kaldor, I Kliewer, SA Lake, DH Leesnitzer, LM Lehmann, JM Lenhard, JM Orband-Miller, LA Miller, JF Mook, RA Noble, SA Oliver, W Parks, DJ Plunket, KD Szewczyk, JR Willson, TM
Citation: Br. Henke et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 1. Discovery of a novel series of potent antihyperglycemic and antihyperlipidemic agents, J MED CHEM, 41(25), 1998, pp. 5020-5036
N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety
Authors: Collins, JL Blanchard, SG Boswell, GE Charifson, PS Cobb, JE Henke, BR Hull-Ryde, EA Kazmierski, WM Lake, DH Leesnitzer, LM Lehmann, J Lenhard, JM Orband-Miller, LA Gray-Nunez, Y Parks, DJ Plunkett, KD Tong, WQ
Citation: Jl. Collins et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 2. Structure-activity relationship and optimization of the phenyl alkyl ether moiety, J MED CHEM, 41(25), 1998, pp. 5037-5054
N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent
Authors: Cobb, JE Blanchard, SG Boswell, EG Brown, KK Charifson, PS Cooper, JP Collins, JL Dezube, M Henke, BR Hull-Ryde, EA Lake, DH Lenhard, JM Oliver, W Oplinger, J Pentti, M Parks, DJ Plunket, KD Tong, WQ
Citation: Je. Cobb et al., N-(2-benzoylphenyl)-L-tyrosine PPAR gamma agonists. 3. Structure-activity relationship and optimization of the N-aryl substituent, J MED CHEM, 41(25), 1998, pp. 5055-5069
Risultati: 1-6 |